COVID-19 Vaccination Personas in Yemen: Insights from Three Rounds of a Cross-Sectional Survey.
COVID-19
Yemen
vaccination
Journal
Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355
Informations de publication
Date de publication:
21 Jul 2023
21 Jul 2023
Historique:
received:
07
06
2023
revised:
10
07
2023
accepted:
19
07
2023
medline:
29
7
2023
pubmed:
29
7
2023
entrez:
29
7
2023
Statut:
epublish
Résumé
We used three rounds of a repeated cross-sectional survey on COVID-19 vaccination conducted throughout the entire territory of Yemen to: (i) describe the demographic and socio-economic characteristics associated with willingness to be vaccinated; (ii) analyse the link between beliefs associated with COVID-19 vaccines and willingness to be vaccinated; and (iii) analyse the potential platforms that could be used to target vaccine hesitancy and improve vaccine coverage in Yemen. Over two-thirds of respondents were either unwilling or unsure about vaccination across the three rounds. We found that gender, age, and educational attainment were significant correlates of vaccination status. Respondents with better knowledge about the virus and with greater confidence in the capacity of the authorities (and their own) to deal with the virus were more likely to be willing to be vaccinated. Consistent with the health belief model, practising one (or more) COVID-19 preventative measures was associated with a higher willingness to get a COVID-19 vaccination. Respondents with more positive views towards COVID-19 vaccines were also more likely to be willing to be vaccinated. By contrast, respondents who believed that vaccines are associated with significant side effects were more likely to refuse vaccination. Finally, those who relied on community leaders/healthcare workers as a trusted channel for obtaining COVID-19-related information were more likely to be willing to be vaccinated. Strengthening the information about the COVID-19 vaccination (safety, effectiveness, side effects) and communicating it through community leaders/healthcare workers could help increase the COVID-19 vaccine coverage in Yemen.
Identifiants
pubmed: 37515086
pii: vaccines11071272
doi: 10.3390/vaccines11071272
pmc: PMC10386099
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Vaccines (Basel). 2022 Jul 21;10(7):
pubmed: 35891323
PLoS One. 2022 Nov 18;17(11):e0274526
pubmed: 36399454
Bull World Health Organ. 2023 Feb 1;101(2):111-120
pubmed: 36733625
Vacunas. 2022 Sep-Dec;23:S52-S59
pubmed: 35813989
Ann Med Surg (Lond). 2022 Jan;73:103206
pubmed: 34976393
PLoS One. 2021 Oct 29;16(10):e0248325
pubmed: 34714827
BMJ Glob Health. 2021 Mar;6(3):
pubmed: 33758012
Clin Infect Dis. 2022 Nov 14;75(10):1827-1833
pubmed: 35134160
Int J Prev Med. 2022 Oct 11;13:130
pubmed: 36452471
Vaccine. 2014 Nov 20;32(49):6649-54
pubmed: 25280436
Saudi Pharm J. 2021 Jul;29(7):734-739
pubmed: 34093059
Transl Behav Med. 2022 Mar 17;12(3):480-485
pubmed: 34865166
Am J Trop Med Hyg. 2021 Sep 03;105(5):1230-1239
pubmed: 34525449
J Infect Dev Ctries. 2022 Jun 30;16(6):993-1000
pubmed: 35797293
J Immunol Res. 2022 Feb 9;2022:3392667
pubmed: 35155687
Vaccines (Basel). 2019 Oct 18;7(4):
pubmed: 31635270